David Cameron’s employer secured a £123 million genetic-sequencing contract after the former prime minister lobbied Matt Hancock to attend a genomics conference, The Times has learnt.

Cameron is a paid adviser to Illumina, a US biotech company that provides gene-sequencing services that can be used to screen DNA for genetic illnesses.

In April 2019 he lobbied Hancock, then health secretary, about the conference, saying: “I understand Jay [Flatley, then executive chairman of Illumina] has sent this direct to your office, but I wanted to i) ensure that you had seen it personally; and ii) strongly endorse their invitation to this significant conference.”

Hancock agreed to go after receiving Cameron’s letter, having not responded to one from the Illumina executive chairman weeks earlier. Cameron’s letter was